Guardant Health
GH
#985
Rank
A$34.17 B
Marketcap
A$254.70
Share price
-3.51%
Change (1 day)
68.48%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Annual Reports

Thumbnail Guardant Health
 Annual Report 2025

Annual Report 2025

Language: English

View Annual Report
Thumbnail Guardant Health
 Annual Report 2024

Annual Report 2024

Language: English

View Annual Report
Thumbnail Guardant Health
 Annual Report 2023

Annual Report 2023

Language: English

View Annual Report
Thumbnail Guardant Health
 Annual Report 2022

Annual Report 2022

Language: English

View Annual Report
Thumbnail Guardant Health
 Annual Report 2021

Annual Report 2021

Language: English

View Annual Report
Thumbnail Guardant Health
 Annual Report 2020

Annual Report 2020

Language: English

View Annual Report
Thumbnail Guardant Health
 Annual Report 2019

Annual Report 2019

Language: English

View Annual Report
Thumbnail Guardant Health
 Annual Report 2018

Annual Report 2018

Language: English

View Annual Report